The founder of the company BioNTech, which is the hope of the whole world with the mRNA-based coronavirus vaccine they have developed, Prof. Uğur Şahin made statements regarding the agenda. Uğur Şahin, who held a video conference with Reuters reporters, stated that a new coronavirus vaccine will be needed sooner or later, but the important issue here is time.
prof. Uğur Şahin stated that the vaccine they developed will continue to be effective. Speaking about the variant named Omicron, Şahin says that he expects such a mutation, but that the new mutation comes a little early. Underlining that there will be no problem, the scientist stated that they can now adapt the vaccine more quickly.
“Vaccination patents can be revoked”
Answering the questions of Reuters reporters about patents, the professor states that he is not against the fact that vaccine patents are open to everyone, but there are some issues at this point. According to Uğur Şahin, if the people who will produce the vaccine are trained and the patent holders have the opportunity to inspect, there is no problem in making the patent open to everyone. Speaking about the frequency of vaccination in his interview, Şahin reminded once again that the coronavirus vaccine can be shot every year like the flu vaccine.
Dr. Özlem Türeci also commented on the agenda. According to Özlem Türeci, who states that mutation is normal and protection from it will only be thanks to high immunity, in order to protect from mutations, vaccination rates need to be increased. On the other hand; Reminding that mRNA technology is not only used specifically for coronavirus, Türeci stated that this technology is also used in potential cancer cells.
26568
